| Literature DB >> 30470303 |
Olga Lancho1, Daniel Herranz2.
Abstract
MYC is one of the most important oncogenes in cancer. Indeed, MYC is upregulated in 50-60% of all tumors. MYC overexpression can be achieved through a variety of mechanisms, including gene duplications, chromosomal translocations, or somatic mutations leading to increased MYC stability. However, recent studies have identified numerous tissue-specific noncoding enhancers of MYC that play major roles in cancer, highlighting long-range transcriptional regulation of MYC as a critical novel mechanism leading to MYC hyperactivation and as a potential target for new therapeutic strategies in the near future. Here we summarize the regions and mechanisms involved in the long-range transcriptional regulation of MYC, underscoring the relevance of MYC enhancers both in normal physiological development and in MYC-driven cancer initiation and progression.Entities:
Keywords: MYC; SNP; cancer; enhancer; long-range transcriptional regulation
Mesh:
Substances:
Year: 2018 PMID: 30470303 PMCID: PMC6260942 DOI: 10.1016/j.trecan.2018.10.003
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025